PIK3CA and breast carcinoma: This is not seen and may suggest alternate receptor and PIK3CA/mTOR interaction in male breast cancer or a dose-based relationship differentiated by male cancers with low estrogen at one end of the spectrum and higher levels of estrogen in females at the opposite end.